
Sign up to save your podcasts
Or


Though currently littered with penny stocks, the landscape for investing in marijuana is improving. Shannon Jones analyzes the recent merger of Aurora Cannabis and MedReleaf, and the impending FDA approval for GW Pharmaceuticals. Plus, we discuss how professional athletes and owners are helping the case by becoming more vocal about marijuana as a device for pain management.
By The Motley Fool4.7
16041,604 ratings
Though currently littered with penny stocks, the landscape for investing in marijuana is improving. Shannon Jones analyzes the recent merger of Aurora Cannabis and MedReleaf, and the impending FDA approval for GW Pharmaceuticals. Plus, we discuss how professional athletes and owners are helping the case by becoming more vocal about marijuana as a device for pain management.

3,234 Listeners

1,494 Listeners

806 Listeners

942 Listeners

531 Listeners

1,180 Listeners

2,183 Listeners

825 Listeners

1,429 Listeners

1,051 Listeners

9,715 Listeners

196 Listeners

826 Listeners

83 Listeners

588 Listeners

1,023 Listeners

50 Listeners